172 related articles for article (PubMed ID: 14608018)
1. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-alpha in feline vaccine-associated sarcomas.
Nieto A; Sánchez MA; Martínez E; Rollán E
Vet Pathol; 2003 Nov; 40(6):651-8. PubMed ID: 14608018
[TBL] [Abstract][Full Text] [Related]
2. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis.
Hershey AE; Dubielzig RR; Padilla ML; Helfand SC
Vet Pathol; 2005 Nov; 42(6):805-11. PubMed ID: 16301577
[TBL] [Abstract][Full Text] [Related]
3. Growth factors in tympanic membrane perforations.
Somers T; Goovaerts G; Schelfhout L; Peeters S; Govaerts PJ; Offeciers E
Am J Otol; 1998 Jul; 19(4):428-34. PubMed ID: 9661750
[TBL] [Abstract][Full Text] [Related]
4. Feline intraocular tumors may arise from transformation of lens epithelium.
Zeiss CJ; Johnson EM; Dubielzig RR
Vet Pathol; 2003 Jul; 40(4):355-62. PubMed ID: 12824506
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas.
Nambiar PR; Jackson ML; Ellis JA; Chelack BJ; Kidney BA; Haines DM
Vet Pathol; 2001 Mar; 38(2):236-8. PubMed ID: 11280384
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
7. Somatic alterations of the p53 tumor suppressor gene in vaccine-associated feline sarcoma.
Banerji N; Kanjilal S
Am J Vet Res; 2006 Oct; 67(10):1766-72. PubMed ID: 17014330
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in New Zealand.
Aberdein D; Munday JS; Dyer CB; Knight CG; French AF; Gibson IR
N Z Vet J; 2007 Oct; 55(5):203-7. PubMed ID: 17928895
[TBL] [Abstract][Full Text] [Related]
9. Expression of basic fibroblast growth factor is associated with a good outcome in patients with squamous cell carcinoma of the esophagus.
Nakamura T; Ozawa S; Kitagawa Y; Shih CH; Ueda M; Kitajima M
Oncol Rep; 2005 Sep; 14(3):617-23. PubMed ID: 16077964
[TBL] [Abstract][Full Text] [Related]
10. Feline vaccine-associated sarcomas: current studies on pathogenesis.
Hendrick MJ
J Am Vet Med Assoc; 1998 Nov; 213(10):1425-6. PubMed ID: 9828935
[No Abstract] [Full Text] [Related]
11. Etiology of feline vaccine-associated sarcomas: history and update.
Bergman PJ
J Am Vet Med Assoc; 1998 Nov; 213(10):1424-5. PubMed ID: 9828934
[No Abstract] [Full Text] [Related]
12. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity with concurrent loss of cell cycle regulation in feline post-traumatic ocular sarcomas.
Carter RT; Giudice C; Dubielzig RR; Colitz CM
J Comp Pathol; 2005 Nov; 133(4):235-45. PubMed ID: 16154137
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992).
Hendrick MJ; Shofer FS; Goldschmidt MH; Haviland JC; Schelling SH; Engler SJ; Gliatto JM
J Am Vet Med Assoc; 1994 Nov; 205(10):1425-9. PubMed ID: 7698923
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of insulin-like growth factor-I, transforming growth factor-beta2, basic fibroblast growth factor and epidermal growth factor-receptor expression in developing rat ovary.
Ergin K; Gürsoy E; Başimoğlu Koca Y; Başaloğlu H; Seyrek K
Cytokine; 2008 Aug; 43(2):209-14. PubMed ID: 18586513
[TBL] [Abstract][Full Text] [Related]
17. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence.
Deniz ML; Kiliç T; Almaata I; Kurtkaya O; Sav A; Pamir MN
Neurosurgery; 2002 Sep; 51(3):753-60; discussion 760. PubMed ID: 12188955
[TBL] [Abstract][Full Text] [Related]
18. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
Rahimi F; Hsu K; Endoh Y; Geczy CL
FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
[TBL] [Abstract][Full Text] [Related]
19. Feline injection site-associated sarcoma: Is it a reason to critically evaluate our vaccination policies?
Kirpensteijn J
Vet Microbiol; 2006 Oct; 117(1):59-65. PubMed ID: 16769184
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
